Zhang Dazhi,MD
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Clinical Intervention Strategy for High-risk Group of Hepatitis B Related Hepatocellular Carcinoma (NCT05256459) | Zhang Dazhi,MD | 2022-05-10 |
Track Zhang Dazhi,MD automatically
Every clearance here is in the API, with alerts when new ones post.